Lebwohl, Mark, Bruce Strober, Amy Schrader, Alvin Li, Thomas Eckmann, Baojin Zhu, William Malatestinic, Julie Birt, Meghan Feely, and Andrew Blauvelt. “6-Month Real World Study to Assess the Effectiveness of Ixekizumab After Switching from IL-23 Inhibitors and Other Biologic Therapies: The CorEvitas Psoriasis Registry”. SKIN The Journal of Cutaneous Medicine 7, no. 6 (November 13, 2023): s232. Accessed July 22, 2024. https://jofskin.org/index.php/skin/article/view/2337.